T2Candida Test Linked To Reduced Time To Invasive Candidiasis Diagnosis, Faster Antifungal Therapy Initiation Among Adults Hospitalized With Septic Shock, Study Finds

Infectious Disease Advisor (12/15, Barowski) reported, “T2Candida, a nonculture-based diagnostic test, is associated with reduced time to invasive candidiasis diagnosis, faster antifungal therapy initiation, and reduced antifungal use among adults hospitalized with septic shock. These study results were published in Open Forum Infectious Diseases.”